🇺🇸 FDA

Drug profile · INN

pneumococcal polysaccharide conjugate vaccine (21-valent)

CAPVAXIVE

EMA: approved J07AL02
Patents linked
0
News articles
0

Quick answer

pneumococcal polysaccharide conjugate vaccine (21-valent) (CAPVAXIVE) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN pneumococcal polysaccharide conjugate vaccine (21-valent)
Brand CAPVAXIVE
ATC code J07AL02

Frequently asked questions

What is pneumococcal polysaccharide conjugate vaccine (21-valent)?

pneumococcal polysaccharide conjugate vaccine (21-valent) (CAPVAXIVE) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for pneumococcal polysaccharide conjugate vaccine (21-valent)?

CAPVAXIVE is a marketed brand name for pneumococcal polysaccharide conjugate vaccine (21-valent). Check FDA Drugs@FDA for the current US label holder and prescribing information.